首页> 美国卫生研究院文献>Journal of Clinical Neurology (Seoul Korea) >Seniors with Parkinsons Disease: Initial Medical Treatment
【2h】

Seniors with Parkinsons Disease: Initial Medical Treatment

机译:帕金森氏病的老年人:初始药物治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Parkinson's disease most often presents after age 60, and patients in this age group are best managed with levodopa therapy as the primary treatment modality. Unlike young-onset parkinsonism (onset <age 40), this older age group is much less prone to subsequent development of levodopa responsive instability (dyskinesias, fluctuations). When these problems do occur in seniors, they usually can be managed by medication adjustments. The treatment goal is to keep patients active and engaged; levodopa dosage should be guided by the patients' responses and not arbitrarily limited to low doses, which may compromise patients' lives.
机译:帕金森氏病最常在60岁以后出现,该年龄组的患者最好以左旋多巴治疗作为主要治疗方式。与年轻的帕金森病(发病年龄小于40岁)不同,该年龄段的人更不容易随后发生左旋多巴反应性不稳定(运动障碍,波动)。当这些问题确实发生在老年人中时,通常可以通过调整用药来解决。治疗目标是使患者保持活跃和参与。左旋多巴的剂量应以患者的反应为指导,而不应随意限制于低剂量,这可能会损害患者的生活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号